Transcatheter Heart Valve Replacement Market (2024 - 2034)
Transcatheter Heart Valve Replacement Market Study by Transcatheter Aortic Valve Replacement and Transcatheter Mitral Valve Repair from 2024 to 2034
Core Findings
FREE CustomizationTranscatheter Heart Valve Replacement Market Outlook (2024 to 2034)
Worldwide revenue from transcatheter heart valve replacement is estimated at US$ 5.31 billion in 2024 and is projected to rise at a CAGR of 13.9% to reach US$ 19.43 billion by the end of 2034. The market for transcatheter aortic replacement has been exhibiting significant growth as heart disorders are becoming more prevalent among the population worldwide.
Transcatheter heart valve replacement offers a solution for aortic valve stenosis, a condition where the aortic valve becomes narrow and stiff. This narrowing of the aortic valve often leads to symptoms like chest pain and shortness of breath, leading individuals to seek transcatheter heart valve replacement when their symptoms become intolerable, thus fueling the expansion of the transcatheter aortic valve replacement market size.
Modern lifestyles are defined by the consumption of junk food, and this tendency has contributed to cardiovascular issues like atherosclerosis, where calcium accumulates on the aortic valve over time, causing it to stiffen and narrow. Individuals suffering from such conditions increasingly turn to transcatheter devices to address these valve obstructions, significantly boosting the demand for transcatheter heart valve replacements. Manufacturers are responding to this demand by supplying efficient, effective, and affordable transcatheter devices to meet this growing demand.
Suppliers capitalize on the needs of individuals aged 60 to 65 who are particularly vulnerable to heart diseases including aortic stenosis, collaborating with hospitals to enhance market penetration targeting. The advent of transcatheter heart valve replacement has transformed the medical landscape, overtaking traditional surgical aortic valve replacements due to its preference among both doctors and patients. This shift has fueled transcatheter aortic valve replacement market growth.
The rising prevalence of heart conditions supports the growing demand for transcatheter devices worldwide, especially among the elderly. Manufacturers predominantly utilize biological valves derived from cow or pig heart tissue to craft efficient transcatheter heart valve replacement devices, catering to patients with heart ailments. Key market players continually adapt to recent advancements, including newly developed transcatheter heart valve replacement devices, to remain competitive and contribute to the ongoing expansion of the transcatheter heart valve replacement market.
| Report Attributes | Details |
|---|---|
| Transcatheter Heart Valve Replacement Market Size (2024E) | US$ 5.31 Billion |
| Forecasted Market Value (2034F) | US$ 19.43 Billion |
| Global Market Growth Rate (2024 to 2034) | 13.9% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 13.5% CAGR |
| China Market Value (2034F) | US$ 471 Million |
| North America Market Share (2024E) | 54.8% |
| East Asia Market Share (2034F) | 9.1% |
| Key Companies Profiled | Braile Biomedica; Edwards Lifesciences Corporation; Cook Medical Inc.; JC Medical Inc.; Venus Medtech Inc.; Medtronic Plc.; Boston Scientific Corporation; Abbott Laboratories; MicroPort Scientific Corp. |
Which Factors are Pushing Sales of Transcatheter Heart Valve Replacement Devices?
“Focus on Development of Second-Generation TAVR Devices for Enhanced Durability”
To prevent immune rejections in patients with severe aortic stenosis, businesses are developing second-generation TAVR devices that are more durable. Recent research has indicated that second-generation TAVR devices offer superior safety-related advantages.
According to these investigations, there is a correlation between transcatheter heart valve devices and a decreased incidence of paravalvular regurgitation, valve embolization, and other bleeding incidents. While choosing between TAVR treatments, new imaging technologies are growing in popularity.
“Increasing Prevalence of Heart Diseases”
Global demand for transcatheter heart valve replacement treatment is being primarily driven by the increasing prevalence of various cardiovascular disorders, particularly valvular heart conditions like aortic stenosis. This factor significantly influences the market, given that valve replacement surgery remains the primary therapy for severe aortic stenosis.
Rising demand for minimally invasive treatments and surgeries is driven by the benefits they offer and is an important transcatheter heart valve replacement market trend. These techniques can help decrease blood loss, reduce pain and trauma, and lower the risk of infection. This leads to faster patient recovery, shorter hospital stays, and fewer visible scars, particularly in heart surgery scenarios.
Market growth is projected to continue in the coming years as more efficient and cost-effective approaches to managing the disease are emerging. Market players are investing in and enhancing their expertise to stay competitive and survive in the market.
What is Restricting Adoption of Transcatheter Heart Valve Replacement?
“High Cost of Valve Replacement Devices and Risks Associated with Treatment”
One of the primary challenges transcatheter heart valve replacement devices providers face is the high cost of these devices. Price is a significant factor influencing purchasing decisions for these devices, posing a limitation for the market due to their relatively expensive nature.
While transcatheter heart valve replacement devices are considered an alternative to open-heart aortic valve replacement, there are inherent risks associated with this treatment. These risks include blood vessel disorders, stroke, irregular heartbeat, heart attack, infection, severe bleeding, and issues related to valve positioning, such as valve migration.
Cost factor remains a crucial consideration for the viability of purchasing transcatheter heart valve replacement products, presenting a competitive barrier within the sector due to the valves' high prices. Industry players are facing this challenge as they strive to survive in the market over the long term.
Country-wise Evaluation
Heart diseases are becoming common among the population across the world in countries including Canada, the United States, Mexico, China, and South Korea. Fact.MR, a leading market intelligence company, states that the South Korean market is projected to expand at a CAGR of 14.7% from 2024 to 2034.
What Attracting Transcatheter Valve Replacement Device Manufacturers to the United States?
“Advanced Medical Infrastructure and Increasing Prevalence of Cardiovascular Disorders”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 2.66 Billion |
| Growth Rate (2024 to 2034) | 14.1% CAGR |
| Projected Value (2034F) | US$ 9.97 Billion |
Heart disease is one of the leading causes of deaths in the United States. Approval from the Food and Drug Administration (FDA) enhances access to TAVR devices for patients. Preference for minimally invasive solutions leads to faster recovery. Transcatheter heart valve replacement devices are included in reimbursement schemes. The well-established healthcare infrastructure in the country helps minimize complications.
- According to research conducted by the American College of Cardiology, valvular heart disorders are rather common among Americans. According to the research, each year over 5 million Americans receive a diagnosis of one of these illnesses. This figure comprises 1.5 million Americans with aortic stenosis, and the approximately 500,000 Americans with severe aortic stenosis represent approximately 33% of the total instances of aortic stenosis in the United States.
What are the Opportunities for Transcatheter Valve Replacement Device Suppliers in China?
“Increasing Elderly Population Susceptible to Cardiovascular Diseases”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 112 Million |
| Growth Rate (2024 to 2034) | 15.4% CAGR |
| Projected Value (2034F) | US$ 471 Million |
Transcatheter heart valve replacement devices primarily serve individuals aged 60 and above, who are at higher risk of cardiovascular diseases and depend on these tools for optimal heart function. China has the world's second-largest population, including a substantial elderly demographic. The nation presents lucrative opportunities for transcatheter heart valve replacement device suppliers to expand their presence and distribute their products. This expansion contributes to China’s leading transcatheter heart valve replacement market share in East Asia.
Category-wise Insights
Demand for transcatheter mitral valve replacement (TMVR) devices is projected to increase at a CAGR of 14.5% from 2024 to 2034. TMVR is being adopted as a less invasive alternative to open-heart surgery for addressing mitral valve stenosis. This has led to an increasing demand for TMVR in the market.
Which Delivery System is Widely Preferred by Healthcare Providers?
“Effectiveness of Transfemoral Delivery Systems in Reducing Chest Pain and Shortness of Breath”
| Attribute | Transfemoral |
|---|---|
| Segment Value (2024E) | US$ 4.66 Billion |
| Growth Rate (2024 to 2034) | 14% CAGR |
| Projected Value (2034F) | US$ 17.23 Billion |
Transfemoral delivery systems, occupying a significant transcatheter heart valve replacement market share, have become more popular in recent years due to their multifaceted advantages, including the option for a fully percutaneous procedure. This attracts patients as it is performed under mild anesthesia and can help in reducing symptoms such as chest pain, shortness of breath, and other symptoms of aortic valve stenosis.
Which End User Accounts for a Significant Share of the Market?
“Hospitals Account for High Market Share Due to Their Capacity for Complex Interventions”
| Attribute | Hospitals |
|---|---|
| Segment Value (2024E) | US$ 4.5 Billion |
| Growth Rate (2024 to 2034) | 13.9% CAGR |
| Projected Value (2034F) | US$ 16.48 Billion |
Hospitals play a significant role compared to ambulatory settings due to their diverse departments and a large number of collaborating doctors. This results in higher demand for transcatheter heart valve replacement devices within hospitals than in other medical facilities. Market players establish yearly contracts with hospitals to ensure priority access for transcatheter heart valve replacements. Moreover, the presence of comprehensive medical infrastructure and hospitals’ capacity for complex interventions are factors influencing market growth.
Market Rivalry
Key players in the transcatheter heart valve replacement market such as Braile Biomedica, Edwards Lifesciences Corporation, and Cook Medical Inc. are focusing on mergers and acquisitions to establish themselves in the market. Companies are also investing in strategic relationships with rivals in other areas. They are adapting themselves to the evolving transcatheter heart valve replacement market trends such as heart attack diagnostics and heart monitoring devices.
- Following FDA clearance, Edwards Lifesciences introduced the Sapien 3 Ultra Resilia Valve in September 2022, making it the first dry-storage transcatheter heart valve made available in the United States.
- The Evolut PRO TAVR System was approved by Medtronic in January 2022 for use in treating severe aortic stenosis in China. As China's population ages, this problem is projected to worsen.
Key Segments of Transcatheter Heart Valve Replacement Market Research
-
By Product :
- Transcatheter Aortic Valve Replacement (TAVR)
- Self-expandable Transcatheter Aortic Valves
- Balloon-Expandable Transcatheter Aortic Valves
- Mechanically Expanded Transcatheter Aortic Valves
- Transcatheter Mitral Valve Repair
- Transcatheter Aortic Valve Replacement (TAVR)
-
By Indication :
- Severe Aortic Valve Stenosis
- Valve-in-Valve Procedures (Failed Bioprosthesis)
- Aortic Regurgitation
-
By End User :
- Hospitals
- Independent Cardiac Catheterization Labs
- Ambulatory Surgical Centers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Background and Foundation Data Points
- 4. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Indication
- 5.1. Severe Aortic Valve Stenosis
- 5.2. Valve-in-Valve Procedures (Failed Bioprosthesis)
- 5.3. Aortic Regurgitation
- 5.4. By End User
- 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product
- 6.1. Transcatheter Aortic Valve Replacement (TAVR)
- 6.2. Transcatheter Mitral Valve Repair
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User
- 7.1. Hospitals
- 7.2. Independent Cardiac Catheterization Labs
- 7.3. Ambulatory Surgical Centers
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. East Asia
- 8.5. South Asia & Oceania
- 8.6. Middle East and Africa (MEA)
- 9. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 10. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 11. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Market Structure Analysis
- 16. Competition Analysis
- 16.1. Braile Biomedica
- 16.2. Edwards Lifesciences Corporation
- 16.3. Cook Medical Inc.
- 16.4. JC Medical Inc.
- 16.5. Venus Medtech Inc.
- 16.6. Medtronic Plc.
- 16.7. Boston Scientific Corporation
- 16.8. Abbott Laboratories
- 16.9. MicroPort Scientific Corp.
- 17. Assumptions and Acronyms Used
- 18. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Indication, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Indication, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Product, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Product, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Product, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Product, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Indication, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Indication, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Indication, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Product, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Product, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by End User, 2024 to 2034
- FAQs -
How big is the transcatheter heart valve replacement market in 2024?
The global market for transcatheter heart valve replacement stands at US$ 5.31 billion in 2024.
What is the projected revenue from transcatheter aortic replacement for 2034?
By 2034, worldwide revenue from transcatheter heart valve replacement procedures is projected to reach US$ 19.43 billion.
How fast are TMVR sales projected to increase?
TMVR sales are forecasted to increase at 13.9% CAGR through 2034.
What is the sales forecast for TMVR in North America?
The market in North America is forecasted to increase at 14.1% CAGR from 2024 to 2034.
At what rate is the market projected to expand in East Asia?
The market in East Asia is projected to expand at a CAGR of 14.5% from 2024 to 2034.
What are the projections for the market in Japan?
Market revenue in Japan is forecasted to rise at a CAGR of 14.1% from 2024 to 2034.
Related Reports
Transcatheter Heart Valve Replacement Market